Literature DB >> 4168732

Plasma lipoproteins in liver disease. I. Immunologically distinct low-density lipoproteins in patients with biliary obstruction.

S Switzer.   

Abstract

Sera from patients with extrahepatic biliary obstruction were found to have an abnormal lipoprotein (obstructive lipoprotein) which failed to react with antibodies to normal lipoproteins of d < 1.063. Preparations of this abnormal lipoprotein made by a combination of immunoprecipitation and multiple polyanion precipitations revealed a high content of free cholesterol (26%) and phospholipids (61%) but only trace amounts of cholesterol esters and triglycerides. Protein content varied from 13% to a corrected low of 5% when ultracentrifugation was also performed. Amino acid analyses of the latter preparations resembled that of lipoproteins of d < 1.006. The reasons underlying the apparent unreactivity of the abnormal lipoprotein were explored. No evidence could be found for soluble antigen-antibody complexes of gamma-globulin and the abnormal lipoprotein, nor for inhibition of antigen-antibody complex formation by serum factors. Purified preparations of obstructive lipoprotein did not react with antisera to high- or low-density lipoproteins prepared from normal sera. Moreover, rabbits immunized with the abnormal lipoproteins produced specific antibodies to this lipoprotein which reacted with a d < 1.006 lipoprotein in normal sera. All other lipoprotein fractions from normal sera were unreactive. It is not known whether this lipoprotein is abnormal by virtue of the presence of a unique peptide or because of secondary alterations in lipoprotein structure.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4168732      PMCID: PMC292936          DOI: 10.1172/JCI105676

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Protein-lipid relationships in human plasma: in biliary cirrhosis, obstructive jaundice, and acute hepatitis.

Authors:  H A EDER; E M RUSS; R A R PRITCHETT; M M WILBER; D P BARR
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

4.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

5.  Lipoprotein patterns of serum obtained by zone electrophoresis.

Authors:  H G KUNKEL; R J SLATER
Journal:  J Clin Invest       Date:  1952-07       Impact factor: 14.808

6.  Solubilization and properties of the apoproteins of the very low- and low-density lipoproteins of human serum.

Authors:  J L Granda; A Scanu
Journal:  Biochemistry       Date:  1966-10       Impact factor: 3.162

Review 7.  Cholesterol ester metabolism.

Authors:  D S Goodman
Journal:  Physiol Rev       Date:  1965-10       Impact factor: 37.312

8.  Transport of lysolecithin by albumin in human and rat plasma.

Authors:  S Switzer; H A Eder
Journal:  J Lipid Res       Date:  1965-10       Impact factor: 5.922

9.  Studies on human serum beta-1-lipoprotein. I. Amino acid composition.

Authors:  S Margolis; R G Langdon
Journal:  J Biol Chem       Date:  1966-01-25       Impact factor: 5.157

10.  Bile acids in the rat: studies in experimental occlusion of the bile duct.

Authors:  G S Boyd; M A Eastwood; N MacLean
Journal:  J Lipid Res       Date:  1966-01       Impact factor: 5.922

View more
  20 in total

Review 1.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

2.  [Serum lipoproteins in acute viral hepatitis (author's transl)].

Authors:  M Baumgarten; M Wienbeck; A Englhardt; G A Martini
Journal:  Klin Wochenschr       Date:  1974-07-01

3.  Lipoproteins in LCAT-deficiency.

Authors:  G Utermann; W Schoenborn; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1972

4.  Lipoproteins--a current perspective of methods and concepts.

Authors:  J L Oncley; N R Harvie
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

5.  Liquid crystalline lipid in the plasma of humans with biliary obstruction.

Authors:  S H Quarfordt; H Oelschlaeger; W R Krigbaum
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

6.  Formation of lipoprotein-X. Its relationship to bile compounds.

Authors:  E Manzato; R Fellin; G Baggio; S Walch; W Neubeck; D Seidel
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

Review 7.  Plasma lipids and lipoproteins in liver disease.

Authors:  N McIntyre
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

8.  [Studies on the structure and metabolism of lipoprotein-X (LP-X), the abnormal plasmalipoprotein in cholestasis (author's transl)].

Authors:  D Seidel
Journal:  Klin Wochenschr       Date:  1977-07-01

9.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: physical and chemical studies of low and high density lipoproteins.

Authors:  K R Norum; J A Glomset; A V Nichols; T Forte
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

10.  Occurrence of an abnormal lipoprotein in patients with liver disease.

Authors:  A Ross; G M Murphy; P A Wilkinson; G L Mills; S Sherlock
Journal:  Gut       Date:  1970-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.